Effect of exogenous β-hydroxybutyrate on BDNF signaling, cognition, and amyloid precursor protein processing in humans with T2D and insulin-resistant rodents

Authors:

Abstract
Ketone supplementation does not alter circulating BDNF levels or cognition in humans with T2D. Acute and chronic ketone supplementation in C57BL/6J mice did not change BDNF protein content or improve recognition memory. Ketone supplementation in C57BL/6J mice positively modulated β-site amyloid precursor protein cleaving enzyme 1 (BACE1) activity, providing a potential future therapeutic strategy.
Funding Information
  • ASC | Alzheimer Society Research Program
  • Canadian Government | Canadian Institutes of Health Research (PJ9-166217)
  • Canadian Government | Canadian Institutes of Health Research (PJT-169116)
  • Canadian Government | Natural Sciences and Engineering Research Council of Canada (RGPIN-2017-03904)

This publication has 49 references indexed in Scilit: